Aura Biosciences to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that members of its executive team will participate in the following upcoming investor conferences: Stifel 2022 Healthcare Conference at the Lotte New York Palace on Wednesday, November 16, 2022. Presentation at 10:55 a.m. ET. 5th Annual 2022 Evercore ISI HealthCONx on Tuesda